Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Search form
Search...
Home
Treg Products
Clinical Trials
People
Contact
CT group
You are here
Home
>
Diabetes
Diabetes
Immune therapy and ß-cell death in type 1 diabetes.
Immune therapy and ß-cell death in type 1 diabetes.
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs ß-cell function.
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs ß-cell function.
How does type 1 diabetes develop?: the notion of homicide or ß-cell suicide revisited.
How does type 1 diabetes develop?: the notion of homicide or ß-cell suicide revisited.
Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs.
Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs.
Expansion of human regulatory T-cells from patients with type 1 diabetes.
Expansion of human regulatory T-cells from patients with type 1 diabetes.
Pages
« first
‹ previous
1
2
3
4
next ›
last »